VTechWorks staff will be away for the winter holidays starting Tuesday, December 24, 2024, through Wednesday, January 1, 2025, and will not be replying to requests during this time. Thank you for your patience, and happy holidays!
 

Alternate pathways of cytotoxic T lymphocyte and natural killer cell activation

dc.contributor.authorGoté, Lisa R.en
dc.contributor.committeechairNagarkatti, Mitzien
dc.contributor.committeememberNagarkatti, Prakash S.en
dc.contributor.committeememberBarta, Otaen
dc.contributor.departmentBiologyen
dc.date.accessioned2014-03-14T21:37:51Zen
dc.date.adate2009-06-11en
dc.date.available2014-03-14T21:37:51Zen
dc.date.issued1995-05-04en
dc.date.rdate2009-06-11en
dc.date.sdate2009-06-11en
dc.description.abstractCD44 is a transmembrane glycoprotein found on a variety of cells including those of myeloid and lymphoid origin. CD44 is highly conserved among various species and is involved in the homing of lymphocytes and monocytes to lymph nodes, Peyer's patches, and sites of inflammation. In the present study, we demonstrate that monoclonal antibody (mAb) 9F3, directed against murine CD44 expressed on cytotoxic T lymphocytes (CTls), can trigger the lytic activity of CTls and redirect CTl-mediated lysis to antigen-negative Fc receptor-positive target cells. Similar redirected lysis was also inducible using mAb MEL - 14, directed against the lymphocyte homing receptor for endothelium (gp - 90MEL-14). The redirected lysis induced by mAbs 9F3 and MEl-14 in the CTL was similar to that induced by mAbs against the aβ T-cell receptor or CD3. In contrast, mAbs directed against CDS, CD45R, and CD11a (LFA-1, lymphocyte function-associated antigen 1) failed to evoke lytic activity. Furthermore, CD44 and MEl-14 mAbs were able to mediate NK cell lysis of the NK-resistant tumor PS15. The current study demonstrates that CD44 and gp_90MEL-14 molecules, in addition to participating in T-cell homing and adhesion, may play a major role in delivering the transmembrane signal to the CTl that triggers the lytic activity, even when the T cell receptor is not occupied. The alternate pathway of CTL activation characterized in this study may exhibit both beneficial and deleterious effects on the host. On one hand, this property may enable CTL to kill cancer cells or virally-infected cells which may fail to express major histocompatibility complex (MHC)-encoded antigens. On the other hand, this alternate pathway may contribute to nonspecific tissue damage seen at sites of inflammation.en
dc.description.degreeMaster of Scienceen
dc.format.extentx, 88 leavesen
dc.format.mediumBTDen
dc.format.mimetypeapplication/pdfen
dc.identifier.otheretd-06112009-063145en
dc.identifier.sourceurlhttp://scholar.lib.vt.edu/theses/available/etd-06112009-063145/en
dc.identifier.urihttp://hdl.handle.net/10919/43130en
dc.language.isoenen
dc.publisherVirginia Techen
dc.relation.haspartLD5655.V855_1995.G684.pdfen
dc.relation.isformatofOCLC# 34404171en
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectadhesion moleculesen
dc.subject.lccLD5655.V855 1995.G684en
dc.titleAlternate pathways of cytotoxic T lymphocyte and natural killer cell activationen
dc.typeThesisen
dc.type.dcmitypeTexten
thesis.degree.disciplineBiologyen
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen
thesis.degree.levelmastersen
thesis.degree.nameMaster of Scienceen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
LD5655.V855_1995.G684.pdf
Size:
2.53 MB
Format:
Adobe Portable Document Format

Collections